90 related articles for article (PubMed ID: 24440439)
1. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
2. Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
Hart RG; Pearce LA; Asinger RW; Herzog CA
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2599-604. PubMed ID: 21903982
[TBL] [Abstract][Full Text] [Related]
3. Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
Kuo L; Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645935
[TBL] [Abstract][Full Text] [Related]
4. Attainment of Target in Therapeutic Range of International Normalized Ratio and Correlates Among Patients on Warfarin Therapy at Jimma Medical Center, Jimma, Ethiopia.
Jada AU; Disassa GM; Melesse BH; Abafogi MM; Abera EG; Jibicho KH; Tukeni KN
Clin Ther; 2024 Apr; 46(4):354-359. PubMed ID: 38429119
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of warfarin anticoagulation and left atrial appendage transcatheter occlusion in the treatment of non-valvular atrial fibrillation and investigation of ET-1, hs-CRP and PDGFs.
Zhang Y; Yao Y; Tao L; Du T; Jia B; Zhou M; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):225-230. PubMed ID: 38678600
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.
Bekelis K; Chang CH; Malenka D; Morden NE
J Clin Neurosci; 2018 Apr; 50():24-29. PubMed ID: 29396074
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study.
Kılıç S; Çelik A; Çekirdekçi E; Altay S; Elçik D; Akboğa MK; Durukan M; Yayla Ç; Zoghi M
Balkan Med J; 2019 Jan; 36(1):17-22. PubMed ID: 30079702
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Warfarin Home INR Monitoring vs Office-Based Monitoring: a Retrospective Claims-Based Analysis.
Van Beek A; Moeyaert M; Ragheb B; Price E; MacEwan JP; Ahmed N; Ansell J
J Gen Intern Med; 2024 May; 39(7):1127-1134. PubMed ID: 38100006
[TBL] [Abstract][Full Text] [Related]
9. Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study.
Ohgushi A; Ohtani T; Nakayama N; Asai S; Ishii Y; Namiki A; Akazawa M; Echizen H
J Pharm Health Care Sci; 2016; 2():2. PubMed ID: 26819747
[TBL] [Abstract][Full Text] [Related]
10. Use of warfarin in long-term care: a systematic review.
Neidecker M; Patel AA; Nelson WW; Reardon G
BMC Geriatr; 2012 Apr; 12():14. PubMed ID: 22480376
[TBL] [Abstract][Full Text] [Related]
11. Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation.
Sato Y; Honda Y; Jun I
Cerebrovasc Dis; 2010; 29(1):73-78. PubMed ID: 19907166
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study.
Leoo T; Lindgren A; Petersson J; von Arbin M
Cerebrovasc Dis; 2008; 25(3):254-60. PubMed ID: 18216468
[TBL] [Abstract][Full Text] [Related]
13. Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin.
Luengsupabul S; Methavigul K; Methavigul R
J Arrhythm; 2020 Jun; 36(3):425-429. PubMed ID: 32528567
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents.
Budak YU; Huysal K; Polat M; Tarakçi G; Uçar H
Biochem Med (Zagreb); 2012; 22(1):121-6. PubMed ID: 22384527
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on the use of warfarin in the United arab emirates.
Shehab A; Elnour A; Abdulle A; Souid AK
Open Cardiovasc Med J; 2012; 6():72-5. PubMed ID: 22723807
[TBL] [Abstract][Full Text] [Related]
16. Surgical drainage of spontaneous sublingual haematoma.
Hamilton A; Beardsley C
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35680279
[TBL] [Abstract][Full Text] [Related]
17. Comparison of warfarin time in the therapeutic range at a pharmacist-run anticoagulation clinic and the RE-LY trial.
Biszewski M; Nitzki-George D; Zhou Y
Am J Health Syst Pharm; 2015 Apr; 72(7):557-62. PubMed ID: 25788509
[TBL] [Abstract][Full Text] [Related]
18. Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial.
Singer DE; Hellkamp AS; Yuan Z; Lokhnygina Y; Patel MR; Piccini JP; Hankey GJ; Breithardt G; Halperin JL; Becker RC; Hacke W; Nessel CC; Mahaffey KW; Fox KA; Califf RM;
J Am Heart Assoc; 2015 Mar; 4(3):e001349. PubMed ID: 25736441
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
20. Comparison of novel oral anticoagulants versus vitamin K antagonists in patients with chronic kidney disease.
Harel Z; Sood MM; Perl J
Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):183-92. PubMed ID: 25636144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
